Latest nitrosamines recall spotlighting need to control pharmaceutical impurities
Quality Matters
NOVEMBER 11, 2022
FDA) workshop , my fellow panelist and I addressed the latest developments in the identification and control of nitrosamines in pharmaceutical products. FDA and other global regulatory agencies have issued public health alerts and guidance documents for manufacturers. Earlier this year, at a U.S. Food and Drug Administration (U.S.
Let's personalize your content